NCT00036257View on ClinicalTrials.gov

Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

April 30, 2003

Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG

CP-461

Trial Locations (5)

12208

Albany Regional Cancer Center, Albany

32806

Cancer Centers of Florida, Orlando

75246

Mary Crowley Medical Research Center (US Oncology), Dallas

75702

Tyler Cancer Center, Tyler

99218

Cancer Care Northwest, Spokane

Sponsors
All Listed Sponsors
collaborator

Cell Pathways

INDUSTRY

collaborator

OSI Pharmaceuticals

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY